Stay updated on Biomarker Response to Pembrolizumab in NSCLC Clinical Trial
Sign up to get notified when there's something new on the Biomarker Response to Pembrolizumab in NSCLC Clinical Trial page.

Latest updates to the Biomarker Response to Pembrolizumab in NSCLC Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedPage revision updated from v3.6.5 to v3.6.6, representing a minor update to the page version. No changes to the displayed study content or details are indicated.SummaryDifference0.0%

- Check15 days agoChange DetectedA new line '2018 ( U.S. NIH Grant/Contract )' was added to the study's funding information, indicating NIH support for the trial.SummaryDifference0.0%

- Check22 days agoNo Change Detected
- Check29 days agoChange DetectedThe page revision label updated from Revision: v3.6.4 to Revision: v3.6.5, signaling a new page version. This update appears to be a backend/versioning change rather than a visible content change.SummaryDifference0.0%

- Check44 days agoChange DetectedThe page’s revision label was updated from v3.6.3 to v3.6.4, indicating a newer release of the page or system.SummaryDifference0.0%

- Check65 days agoChange DetectedRevision label updated from v3.6.2 to v3.6.3, indicating a minor update to the page build or content.SummaryDifference0.0%

- Check73 days agoChange DetectedRevision updated from v3.6.0 to v3.6.2, representing a small version update to the page's backend/template without altering visible study information.SummaryDifference0.0%

Stay in the know with updates to Biomarker Response to Pembrolizumab in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Biomarker Response to Pembrolizumab in NSCLC Clinical Trial page.